| 697378 |
NEURO-ONCOLOGY |
EMBR-33. YAP1 FUNCTION IN SHH MEDULLOBLASTOMA PROGRESSION AND IMMUNE EVASION |
2021-06-01 |
10.1093/neuonc/noab090.050 |
Abdelfattah Nourhan, Natarajan Sivaraman, Baskin David, Yun Kyuson |
| 697377 |
NEURO-ONCOLOGY |
EMBR-09. EXAMINING THE ROLE OF THE DEVELOPMENTALLY ENCODED TRANSCRIPTION FACTOR, LHX9, IN GROUP 3 MEDULLOBLASTOMA |
2021-06-01 |
10.1093/neuonc/noab090.027 |
Injac Sarah, Rivas Bryan, Arabzade Amir, Zhao Yanhau, Parsons D William, Mack Stephen |
| 697376 |
NEURO-ONCOLOGY |
LGG-13. PILOCYTIC ASTROCYTOMAS WITH NOVEL BRAF FUSIONS DEMONSTRATE MAPK PATHWAY ACTIVATION |
2021-06-01 |
10.1093/neuonc/noab090.137 |
Chatwin Hannah, Lind Katherine, DeSisto John, Sanford Bridget, Gilani Ahmed, Green Adam |
| 697375 |
NEURO-ONCOLOGY |
HGG-30. BRAIN PENETRANT HDAC INHIBITOR RG2833 SYNERGIZES WITH LOMUSTINE AND RADIATION TO INDUCE DIPG CELL DEATH |
2021-06-01 |
10.1093/neuonc/noab090.094 |
Barnett Katherine, Novak Orlandi, Eberhart Charles, Raabe Eric |
| 697374 |
NEURO-ONCOLOGY |
HGG-29. VENETOCLAX SYNERGIZES WITH RADIATION THERAPY FOR THE TREATMENT OF DIPG |
2021-06-01 |
10.1093/neuonc/noab090.093 |
Balakrishnan Ilango, Chetty Senthilnath Lakshmana, Madhavan Krishna, Fosmire Susan, Pierce Angela, walker Faye, Dahl Nathan, Mitra Siddhartha, Vibhakar Rajeev, Venkataraman Sujatha |
| 697373 |
NEURO-ONCOLOGY |
EMBR-04. BET INHIBITION TARGETS RADIOTHERAPY RESISTANCE IN H3K27ME3-DEFICIENT GROUP 3 MEDULLOBLASTOMA |
2021-06-01 |
10.1093/neuonc/noab090.022 |
Gabriel Nishanth, Balaji Kumaresh, Inkman Matthew, Jayachandran Kay, Zhang Jin, Dahiya Sonika, Goldstein Michael |
| 697372 |
NEURO-ONCOLOGY |
RARE-24. IDENTIFYING INDIVIDUALS WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMORS AT RISK FOR HEREDITARY CANCER SYNDROMES USING THE UTAH POPULATION DATABASE |
2021-06-01 |
10.1093/neuonc/noab090.185 |
Whipple Nicholas, Kohlmann Wendy, Cheshier Samuel, Yu Zhe, Curtin Karen, Schiffman Joshua |
| 697371 |
NEURO-ONCOLOGY |
HGG-34. A DNA DAMAGE REPAIR SIGNATURE IN PRIMARY AND RECURRENT PEDIATRIC HIGH-GRADE GLIOMAS: PROGNOSTIC AND THERAPEUTIC VALUE |
2021-06-01 |
10.1093/neuonc/noab090.098 |
Entz-Werle Natacha, Poidevin Laetitia, Nazarov Petr, Lhermitte Benoit, Chenard Marie Pierre, Poch Olivier, Dontenwill Monique, Van Dyck Eric |
| 697370 |
NEURO-ONCOLOGY |
HGG-19. 5-AMINOLEVULINIC ACID (5-ALA)-GUIDED RESECTION OF PEDIATRIC BRAIN TUMORS |
2021-06-01 |
10.1093/neuonc/noab090.084 |
Schwake Michael, Bruns Ann-Katrin, Müther Michael, Schipmann Stephanie, Stummer Walter |
| 697369 |
NEURO-ONCOLOGY |
ATRT-05. REPURPOSED ANTI-MALARIAL QUINACRINE ACTIVATES P53 AND INHIBITS ATRT TUMORIGENICITY |
2021-06-01 |
10.1093/neuonc/noab090.004 |
Kaur Harpreet, Parthasarathy Akhila, Guo Huizi, Green Peter C, Akhtarkhavari Sepehr, Eberhart Charles G, Raabe Eric H |
